NATF is a proud member of the Coalition to Prevent DVT. | Date: | Saturday, September 27, 2008 | ||
| Who should attend? | Physicians, Nurses, Physician Assistants, Pharmacists, Hospitalists, and Hospital Administrators interested in thrombosis prevention and treatment. | ||
| Accreditation/Designation Statements: | This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Med-IQ and North American Thrombosis Forum (NATF). Med-IQ is accredited by the ACCME to provide continuing medical education for physicians. Med-IQ designates this educational activity for a maximum of 7.0 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity. Med-IQ is Provider approved by the California Board of Registered Nursing, Provider Number CEP 14745, for 7 contact hours.
7.0 contact hours (0.700 CEUs) of credit for pharmacists. ACPE #476-999-08-010-L01-P. This program is designed for all pharmacists. |
||
| Tuition: | $55.00 (All Attendees)* | ||
| * NATF Members receive a 25% discount ($41.00). Membership is FREE, click here to learn more. | |||
| Location: | The Fairmont Copley Plaza Hotel, 138 St. James Avenue, Boston, MA 02116 | ||
| Directors: | Samuel Z. Goldhaber, MD, Jawed Fareed, PhD, and Arthur A. Sasahara, MD | ||
| Objectives: | This 1-day symposium emphasizing clinical science and professional education is intended to provide a concise, state-of-the-art overview of prophylaxis measures and critical developments in the diagnosis, treatment, and prevention of thrombotic disorders. Focused sessions in 5 key areas include 1) translational research, 2) clinical research, 3) prevention and education, 4) public policy, and 5) advocacy. The program will be in lecture format with discussion, question and answer sessions following each presentation. Course Participants will receive a comprehensive syllabus and CD ROM, which includes lecture outlines with slide panels and extensive up-to-date bibliographies. |
||
| NATF: | Board of Directors |
Samuel Z. Goldhaber, MD Jawed Fareed, PhD Arthur A. Sasahara, MD John Fanikos, RPh, MBA |
|
Scientific Advisory Committee |
Stephen Fredd, MD Carlos Jerjes-Sanches Diaz, MD Kenneth V. Leeper, MD Geno Merli, MD Gundu Rao, PhD Jeanine M. Walenga, PhD Jeffrey I. Weitz, MD Ann K. Wittkowsky, PharmD |
||
International Advisory Committee |
Henri M. Bounameaux, MD Benjamin Brenner, MD Sylvia Haas, MD Stavros Konstantinides, MD Ajay K. Kakkar, MD, PhD Vijay V. Kakkar, MD |
||
Advocacy Committee |
Elizabeth Aluck Jose Alvarez-Stelling Kelly Clark Jennifer Combs, MSN, ARNP Mike Hefron Mark Lindsay Ruth B. Morrison, RN, BSN, CVN |
||
| FACULTY: | Joseph S. Alpert, MD Mary Amatangelo, RN Deepak Bhatt, MD John Fanikos, RPh, MBA Jawed Fareed, PhD Karen Fiumara, PharmD Brian F. Gage, MD |
Samuel Z. Goldhaber, MD Allen Kachalia, MD Craig M. Kessler, MD Joann E. Manson, MD, DrPh Arthur A. Sasahara, MD Susan B. Shurin, MD Suresh Vedantham, MD Jeanine M. Walenga, PhD |
|
SCHEDULE - THROMBOSIS SUMMIT 2008 Saturday, September 27, 2008 Fairmont Copley Plaza Hotel |
|||
| 6:45 AM | 7:45 AM | Registration and Breakfast | |
| 7:45 AM | 8:00 AM | Seating | |
| 8:00 AM | 8:15 AM | Welcome and Opening Remarks Arthur A. Sasahra, MD Jawed Fareed, PhD Samuel Z. Goldhaber, MD |
|
| TRANSLATIONAL RESEARCH | |||
| 8:15 AM | 8:40 AM | Pharmacogenomics of Warfarin: Are the Promises Justified? Brian F. Gage, MD, MSc Discussion, Q & A Session |
|
| 8:40 AM | 9:05 AM | Heparin-Induced Thrombocytopenia: Controversies and Updates |
|
| CLINICAL RESEARCH | |||
| 9:05 AM | 9:30 AM | Controversies Surrounding the Optimal Therapy of Extensive Leg DVT: The Newly NHLBI-funded ATTRACT Trial |
|
| 9:30 AM | 9:55 AM | Bar-Coding Inpatient Medications to Improve Patient Safety |
|
| 9:55 AM | 10:10 AM | Morning Break | |
| 10:10 AM | 10:35 AM | Unfractionated and LMWH: Safety and Regulatory Concerns |
|
| 10:35 AM | 11:00 AM | Estrogen and Thrombosis: A Women's Health Issue |
|
| NATF FELLOWSHIP | |||
| 11:00 AM | 11:10 AM | NATF Traveling Fellowship Awards 2008 |
|
| KEYNOTE SPEAKER | |||
| 11:10 AM | Noon | Keynote Global Thrombosis Summit Address |
|
| Noon | 1:10 PM | Lunch (provided) | |
| PREVENTION & EDUCATION | |||
| 1:10 PM | 1:35 PM | Anticoagulation Management & Warfarin Safety: A Systems Approach |
|
| 1:35 PM | 2:00 PM | Anticoagulation Bridging: Hope or Hype |
|
| 2:00 PM | 2:25 PM | Prevention of Stroke |
|
| 2:25 PM | 2:50 PM | Prevention of Venous Thromboembolism: Can Computers Help? |
|
| 2:50 PM | 3:15 PM | Thrombosis and Cancer |
|
| 3:15 PM | 3:30 PM | Afternoon Break | |
| PUBLIC POLICY & ADVOCACY | |||
| 3:30 PM | 4:00 PM | Policies to Prevent and Minimize the Burden of Coronary Heart Disease: Strategies Based upon a Global Registry |
|
| 4:00 PM | 4:30 PM | The National Heart, Lung and Blood Institute (NHLBI) Susan B. Shurin, MD Discussion, Q & A Session |
|
| 4:30 PM | 5:00 PM | Concluding Comments, Future Plans, Wrap-Up |
|
| 5:00 PM | Adjourn | ||
| * Each lecture will close with a 5-10 minute discussion/question and answer period. | |||
Med-IQ is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education.